Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
about
Increasing the cytotoxicity of doxorubicin in breast cancer MCF-7 cells with multidrug resistance using a mesoporous silica nanoparticle drug delivery systemNanomedicine strategies for treatment of secondary spinal cord injury.Nanomedicine for treating spinal cord injury.Affinity for, and localization of, PEG-functionalized silica nanoparticles to sites of damage in an ex vivo spinal cord injury model.Nanotechnology inspired tools for mitochondrial dysfunction related diseases.Mesoporous silica nanoparticles synthesized from liquid crystal display manufacturing extracts as a potential candidate for a drug delivery carrier: evaluation of their safety and biocompatibility.Neurodegenerative disorders and nanoformulated drug development.Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery (review).Dynamic and cellular interactions of nanoparticles in vascular-targeted drug delivery.Mesoporous silica nanoparticles in nanotechnology.Nanoparticulate strategies for the five R's of traumatic spinal cord injury intervention: restriction, repair, regeneration, restoration and reorganization.Preparation, characterization, and cytotoxic effects of liposomal nanoparticles containing cisplatin: an in vitro study.In vitro effect of imatinib mesylate loaded on polybutylcyanoacrylate nanoparticles on leukemia cell line K562.Differential Effects of Polymer-Surface Decoration on Drug Delivery, Cellular Retention, and Action Mechanisms of Functionalized Mesoporous Silica Nanoparticles.Necrotic Effect versus Apoptotic Nature of Camptothecin in Human Cervical Cancer Cells.Preparation, Characterization and Cytotoxic Effects of Pegylated Nanoliposomal Containing Carboplatin on Ovarian Cancer Cell Lines.Breast cancer cells imaging by targeting methionine transporters with gadolinium-based nanoprobeSilica nanoparticles grafted with phthalocyanines: photophysical properties and studies in artificial lysosomal fluid
P2860
Q33582877-1FCB509E-642E-4571-A785-30B1FCDF5FA1Q35063603-8D62C51A-188B-4BCF-A054-23B55DEB6D45Q35216746-550396EE-B5C8-4192-88EA-CA9331216108Q36547886-A06E0D72-913C-42EE-BCB6-7AABFC8C68BEQ36703351-97497458-B8C4-44D0-8E19-CD32AA5CFBB9Q37233323-B4915B86-3B92-42BB-9DE9-2CA7BFF13301Q37538771-A5B3C107-09CF-46F3-9569-21AA4DC5C07CQ37771030-84EC0760-CD37-4170-BF37-88FF337A4D33Q37804385-66F214CC-0174-4421-ADFF-351FF47EDCE1Q38020874-7005BBC4-CA74-4052-977A-B440EAAD0825Q38189492-8572E634-3F2F-4AE6-8892-8E263A5EC258Q38771030-BCE2121D-E7FC-4FAD-B29B-B3A162D2B3DAQ38774025-05BD68EA-F8D9-43D1-994A-947E98EB0F35Q38845880-878106BA-E368-4496-B24F-DDCBD2C9D279Q41787096-55760916-146A-436E-90F6-96E0D4F45EF5Q50908152-C41E97D6-EA1E-4BB4-A5E4-A3CADC217002Q57183283-A54BDE6F-6A4A-4283-906D-E991C2F99E63Q58839231-50271C13-157A-4F68-AAAD-E0C949738972
P2860
Functionalized mesoporous silica nanoparticle-based drug delivery system to rescue acrolein-mediated cell death.
description
2008 nî lūn-bûn
@nan
2008年の論文
@ja
2008年学术文章
@wuu
2008年学术文章
@zh
2008年学术文章
@zh-cn
2008年学术文章
@zh-hans
2008年学术文章
@zh-my
2008年学术文章
@zh-sg
2008年學術文章
@yue
2008年學術文章
@zh-hant
name
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@en
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@nl
type
label
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@en
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@nl
prefLabel
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@en
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@nl
P2093
P2860
P356
P1433
P1476
Functionalized mesoporous sili ...... acrolein-mediated cell death.
@en
P2093
Albena Ivanisevic
Richard B Borgens
Youngnam Cho
P2860
P304
P356
10.2217/17435889.3.4.507
P577
2008-08-01T00:00:00Z